NCT00483964View on ClinicalTrials.gov

A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

September 30, 2007

Conditions
Schizophrenia
Interventions
DRUG

Bacopa monnieri

DRUG

Nardostachys jatamansi

DRUG

Olanzapine

Trial Locations (1)

400612

Q.Mundewadi Ayurvedic Research & Charitable Trust, Mumbra,Thane

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Q.Mundewadi Ayurvedic Research & Charitable Trust

OTHER

NCT00483964 - A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia | Biotech Hunter | Biotech Hunter